Pharmalicensing Logo - Go to Home page
Register or Sign in to Save this opportunity, or Send an Inquiry.
Droperidol 1.25mg/1ml Ampoule
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Injectable for treatment of PONV and nausea and vomiting during post-operative PCA
Send an Inquiry
RE:
Participants
You

Droperidol 1.25mg/1ml ampoule, solution for injection ready to use.


Droperidol is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV) in adults, children and adolescents. Another indication is the prevention of nausea and vomiting induced by morphine derivates during post-operative patient controlled analgesia (PCA) in adults.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country specific or regional distribution contract.

FEATURED
Last Updated Nov 2014
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION
Company Logo
Orpha Swiss GmbH
Untere Hesilbachstr. 41a
Kuesnacht 8700
Switzerland
Opportunity Contact
Orpha Swiss GmbH
+41 44 910 33 33
Visit Website

Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833